Stifel Nicolaus Issues Pessimistic Forecast for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its target price decreased by research analysts at Stifel Nicolaus from $101.00 to $95.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 6.41% from the company’s previous close.

CL has been the topic of a number of other reports. TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Barclays dropped their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Stock Performance

NYSE:CL traded up $0.72 during trading hours on Friday, reaching $89.28. The company had a trading volume of 1,330,363 shares, compared to its average volume of 4,672,949. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $72.94 billion, a PE ratio of 25.57, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The business’s 50 day moving average price is $92.32 and its 200-day moving average price is $97.85. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.37% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CL. Atomi Financial Group Inc. grew its holdings in shares of Colgate-Palmolive by 6.5% during the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock worth $590,000 after purchasing an additional 394 shares during the period. Crossmark Global Holdings Inc. lifted its position in Colgate-Palmolive by 4.3% in the fourth quarter. Crossmark Global Holdings Inc. now owns 173,831 shares of the company’s stock valued at $15,803,000 after buying an additional 7,105 shares during the last quarter. Ballentine Partners LLC boosted its stake in Colgate-Palmolive by 2.2% during the fourth quarter. Ballentine Partners LLC now owns 21,007 shares of the company’s stock worth $1,910,000 after buying an additional 460 shares during the period. ZWJ Investment Counsel Inc. increased its position in shares of Colgate-Palmolive by 11.1% during the fourth quarter. ZWJ Investment Counsel Inc. now owns 3,881 shares of the company’s stock valued at $353,000 after acquiring an additional 388 shares during the last quarter. Finally, Koshinski Asset Management Inc. increased its position in shares of Colgate-Palmolive by 7.2% during the fourth quarter. Koshinski Asset Management Inc. now owns 8,292 shares of the company’s stock valued at $754,000 after acquiring an additional 558 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.